Shares of Sun Pharmaceuticals will remain in focus, as the ₹675-crore buyback offer opens on Thursday. The company offers ₹900 a share to mop up 75 lakh shares from shareholders whose name appeared on its book, as on July 15. The offer will be on a proportionate basis. Sun Pharma had said the buyback aims to return surplus funds to investors. Promoters had indicated their intention to sell in the buyback but without altering their current shareholding status.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.